Global Bioengineered Protein Drugs Market Research Report 2019 (Includes Business Impact of COVID-19)

  • TBI798432
  • March 14, 2019
  • Global
  • 90 pages
  • QY Market Research
                                          

"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Bioengineered Protein Drugs market. Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Bioengineered Protein Drugs market." Bioengineered proteins are designed as the fundamental participants in all biological processes, represent as powerful therapeutic agents and include a broad range of products such as growth factors, hormones, vaccines, monoclonal antibodies, cytokines and few others. These special drugs are gaining attention across pharmaceutical industries due to their specificity, safety, bioreactivity and success rate in treating life-threatening diseases and injuries. The global Bioengineered Protein Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Bioengineered Protein Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bioengineered Protein Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: Abbot Amgen Baxter Bayer Eli Lilly GlaxoSmithKline Fresenius Kabi Hoffman-la-Roche Johnson & Johnson Merck Segment by Regions North America Europe China Japan Segment by Type Recombinant protein drugs Peptide hormones Vaccines Therapeutic enzymes Monoclonal antibodies Cytokines Replacement proteins Peptide antibiotics Blood products Segment by Application Fractionation Bioreactors and microbial cell fermentation Genetic engineering Genetically modified organisms Pharming Bioengineered protein drugs produced by transgenic microorganisms, plants and animals Cell culture Others

Table of Contents

Executive Summary
1 Bioengineered Protein Drugs Market Overview
    1.1 Product Overview and Scope of Bioengineered Protein Drugs
    1.2 Bioengineered Protein Drugs Segment by Type
        1.2.1 Global Bioengineered Protein Drugs Production Growth Rate Comparison by Type (2014-2025)
        1.2.2 Recombinant protein drugs
        1.2.3 Peptide hormones
        1.2.4 Vaccines
        1.2.5 Therapeutic enzymes
        1.2.6 Monoclonal antibodies
        1.2.7 Cytokines
        1.2.8 Replacement proteins
        1.2.9 Peptide antibiotics
        1.2.10 Blood products
    1.3 Bioengineered Protein Drugs Segment by Application
        1.3.1 Bioengineered Protein Drugs Consumption Comparison by Application (2014-2025)
        1.3.2 Fractionation
        1.3.3 Bioreactors and microbial cell fermentation
        1.3.4 Genetic engineering
        1.3.5 Genetically modified organisms
        1.3.6 Pharming
        1.3.7 Bioengineered protein drugs produced by transgenic microorganisms, plants and animals
        1.3.8 Cell culture
        1.3.9 Others
    1.4 Global Bioengineered Protein Drugs Market by Region
        1.4.1 Global Bioengineered Protein Drugs Market Size Region
        1.4.2 North America Status and Prospect (2014-2025)
        1.4.3 Europe Status and Prospect (2014-2025)
        1.4.4 China Status and Prospect (2014-2025)
        1.4.5 Japan Status and Prospect (2014-2025)
    1.5 Global Bioengineered Protein Drugs Market Size
        1.5.1 Global Bioengineered Protein Drugs Revenue (2014-2025)
        1.5.2 Global Bioengineered Protein Drugs Production (2014-2025)

2 Global Bioengineered Protein Drugs Market Competition by Manufacturers
    2.1 Global Bioengineered Protein Drugs Production Market Share by Manufacturers (2014-2019)
    2.2 Global Bioengineered Protein Drugs Revenue Share by Manufacturers (2014-2019)
    2.3 Global Bioengineered Protein Drugs Average Price by Manufacturers (2014-2019)
    2.4 Manufacturers Bioengineered Protein Drugs Production Sites, Area Served, Product Types
    2.5 Bioengineered Protein Drugs Market Competitive Situation and Trends
      ...
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form